Prostate Cancer

CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Study of PSMA PET/CT Imaging to Help Select Men With Low-Risk Prostate Cancer for Active Surveillance

This clinical trial update describes a study evaluating PSMA PET/CT imaging to guide selection of men with low-risk prostate cancer for acti…

CLINICAL_TRIALS trial_result · 2025-09-15

Clinical Trial Update: Vudalimab (XmAb20717) in Combination With Standard of Care Treatment in Patients With Metastatic Castration Sensitive Prostate Cancer [Phase 1]

A Phase 1 trial evaluating Vudalimab (XmAb20717) in combination with standard of care for metastatic castration-sensitive prostate cancer wa…

CLINICAL_TRIALS other · 2025-09-15

Clinical Trial Update: Study on Triple Therapy Combined With HIFU for High-Tumor-Burden mHSPC [NA]

Clinical trial update describing a study on triple therapy combined with high-intensity focused ultrasound (HIFU) for high-tumor-burden meta…

CLINICAL_TRIALS research · 2025-09-15

Clinical Trial Update: Stereotactic Body Radiation Therapy (SBRT) for Prostate Cancer [NA]

This document reports an ongoing clinical trial evaluating stereotactic body radiation therapy (SBRT) for prostate cancer, sponsored by Hoag…

CLINICAL_TRIALS trial_result · 2025-09-12

Clinical Trial Update: Radioligand fOr locAl raDiorecurrent proStaTe cancER [Phase 1, Phase 2]

This clinical trial update notes the completion of Phase 1 and Phase 2 trials evaluating a radioligand therapy for locally radiorecurrent pr…

CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Multiparametric MRI in Men With Prostate Cancer Enrolled in Active Surveillance [NA]

This clinical trial update indicates ongoing enrollment for a study evaluating multiparametric MRI in men with prostate cancer on active sur…

CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Pelvic Nodes Ultra-Hypo vs Conventionally Fractionated IMRT With HDR Boost in Prostate Cancer. [NA]

The clinical trial NCT05820633 evaluating pelvic nodal ultra-hypofractionated IMRT with HDR boost versus conventional fractionated IMRT in p…

CLINICAL_TRIALS research · 2025-09-12

Clinical Trial Update: Diagnostic Performance of PSMA PET/CT for Pre-operative Lymph Node Assessment in Intermediate and High-risk Non-metastasic Prostate Cancer (PREOP-PSMA ). [NA]

A recruiting clinical trial assessing the diagnostic performance of PSMA PET/CT for pre-operative lymph node assessment in intermediate- and…

CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: High-Dose Rate Brachytherapy and Stereotactic Body Radiation Therapy in Treating Patients With Prostate Cancer [Phase 1]

Phase 1 clinical trial evaluating high-dose-rate brachytherapy combined with stereotactic body radiation therapy for prostate cancer, includ…

CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: Intrapatient Comparison of Urinary Radioactivity Following Piflufolastat (18F) and Flotufolastat (18F) PET in Men With Low PSA Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy [Phase 4]

Phase 4 study comparing intrapatient urinary radioactivity between Piflufolastat F-18 and Flotufolastat F-18 PET imaging in men with low PSA…

CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: Health Gatherings - For Your Health After Cancer [NA]

This clinical trial update from the University of Miami reports completed results for a study involving prostate and related male genital ca…

CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer [Phase 2]

This clinical trial update describes a Phase 2 study evaluating schedule de-escalation of 177Lu-PSMA-617 for metastatic castration-resistant…

CLINICAL_TRIALS research · 2025-09-11

Clinical Trial Update: Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer [Phase 3]

Phase 3 clinical trial evaluating standard systemic therapy with or without definitive treatment for metastatic prostate cancer; currently r…

CLINICAL_TRIALS trial_result · 2025-09-11

Clinical Trial Update: PYLARIFY® PET/CT or PET/MRI in Men With Favorable Intermediate Risk (FIR) Prostate Cancer [Phase 4]

A Phase 4 clinical trial update indicates that PYLARIFY PET/CT or PET/MRI is being studied in men with favorable intermediate-risk prostate …

CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: A Study to Evaluate the Effect of Rifampicin on the Pharmacokinetics of Oral HRS-5041 in Healthy Subjects [Phase 1]

A Phase 1 pharmacokinetic interaction study evaluating the effect of rifampicin on the PK of oral HRS-5041 in healthy subjects has been comp…

CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: A Trial for a Preliminary Estimate of the Effectiveness of a Novel Theoretical Framework [NA]

This completed clinical trial from the University of Arkansas provides a preliminary estimate of the effectiveness of a novel theoretical fr…

CLINICAL_TRIALS research · 2025-09-10

Clinical Trial Update: PSMA PET Combined With MRI for the Detection of PCa [Phase 3]

Phase 3 clinical trial update indicating recruitment is ongoing for using PSMA PET combined with MRI to detect prostate cancer.

CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: A Study on the Safety and Efficacy of LAE001 in the Treatment of Metastatic Prostate Cancer [Phase 1, Phase 2]

A terminated Phase 1/2 study evaluating the safety and efficacy of LAE001 in metastatic prostate cancer.

CLINICAL_TRIALS trial_result · 2025-09-10

Clinical Trial Update: AGN-CognI.Q Acute Dose Safety and Pharmacokinetics Dose-Response in Prostate Cancer Patients [Phase 1]

Phase 1 study evaluating the safety and pharmacokinetics (acute dose, dose-response) of AGN-CognI.Q in prostate cancer patients. The study s…

CLINICAL_TRIALS trial_result · 2025-09-09

Clinical Trial Update: Effects of Triptorelin Pamoate 6-month When Given to Adult Chinese Participants With Advanced Cancer in the Prostate [Phase 3]

Phase 3 trial evaluating a 6-month regimen of triptorelin pamoate in adult Chinese men with advanced prostate cancer; results have been post…